Amedeo's Top 20

Amedeo Smart

Independent Medical Education

17 June 2019

Multidisciplinary Journal Club

  1. Inge TH, Courcoulas AP, Jenkins TM, Michalsky MP, et al.
    Five-Year Outcomes of Gastric Bypass in Adolescents as Compared with Adults.
    N Engl J Med 2019;380:2136-2145.

  1. Robert C, Grob JJ, Stroyakovskiy D, Karaszewska B, et al.
    Five-Year Outcomes with Dabrafenib plus Trametinib in Metastatic Melanoma.
    N Engl J Med 2019.

  2. Davis ID, Martin AJ, Stockler MR, Begbie S, et al.
    Enzalutamide with Standard First-Line Therapy in Metastatic Prostate Cancer.
    N Engl J Med 2019.

  3. Jain N, Keating M, Thompson P, Ferrajoli A, et al.
    Ibrutinib and Venetoclax for First-Line Treatment of CLL.
    N Engl J Med 2019;380:2095-2103.

  4. Dunlay SM, Givertz MM, Aguilar D, Allen LA, et al.
    Type 2 Diabetes Mellitus and Heart Failure: A Scientific Statement From the American Heart Association and the Heart Failure Society of America.
    Circulation 2019.

  1. Reaven PD, Emanuele NV, Wiitala WL, Bahn GD, et al.
    Intensive Glucose Control in Patients with Type 2 Diabetes - 15-Year Follow-up.
    N Engl J Med 2019;380:2215-2224.

  2. Im SA, Lu YS, Bardia A, Harbeck N, et al.
    Overall Survival with Ribociclib plus Endocrine Therapy in Breast Cancer.
    N Engl J Med 2019.

  3. Sparano JA, Gray RJ, Ravdin PM, Makower DF, et al.
    Clinical and Genomic Risk to Guide the Use of Adjuvant Therapy for Breast Cancer.
    N Engl J Med 2019.

  4. Pittas AG, Dawson-Hughes B, Sheehan P, Ware JH, et al.
    Vitamin D Supplementation and Prevention of Type 2 Diabetes.
    N Engl J Med 2019.

  5. Wang Y, Farooq U, Link BK, Larson MC, et al.
    Late Relapses in Patients With Diffuse Large B-Cell Lymphoma Treated With Immunochemotherapy.
    J Clin Oncol 2019.

  1. Chi KN, Agarwal N, Bjartell A, Chung BH, et al.
    Apalutamide for Metastatic, Castration-Sensitive Prostate Cancer.
    N Engl J Med 2019.

  2. Garon EB, Hellmann MD, Rizvi NA, Carcereny E, et al.
    Five-Year Overall Survival for Patients With Advanced NonSmall-Cell Lung Cancer Treated With Pembrolizumab: Results From the Phase I KEYNOTE-001 Study.
    J Clin Oncol 2019.

  3. Andre F, Ismaila N, Henry NL, Somerfield MR, et al.
    Use of Biomarkers to Guide Decisions on Adjuvant Systemic Therapy for Women With Early-Stage Invasive Breast Cancer: ASCO Clinical Practice Guideline Update-Integration of Results From TAILORx.
    J Clin Oncol 2019.

  4. Al-Batran SE, Homann N, Pauligk C, Goetze TO, et al.
    Perioperative chemotherapy with fluorouracil plus leucovorin, oxaliplatin, and docetaxel versus fluorouracil or capecitabine plus cisplatin and epirubicin for locally advanced, resectable gastric or gastro-oesophageal junction adenocarcino
    Lancet 2019;393:1948-1957.

  5. Kambhampati S, Bauer KE, Bracci PM, Keenan BP, et al.
    Nivolumab in patients with advanced hepatocellular carcinoma and Child-Pugh class B cirrhosis: Safety and clinical outcomes in a retrospective case series.
    Cancer 2019.

  1. Hurvitz SA, Martin M, Jung KH, Huang CS, et al.
    Neoadjuvant Trastuzumab Emtansine and Pertuzumab in Human Epidermal Growth Factor Receptor 2-Positive Breast Cancer: Three-Year Outcomes From the Phase III KRISTINE Study.
    J Clin Oncol 2019.

  2. Sharma S, Schlusser KE, de la Torre P, Tambussi G, et al.
    The benefit of immediate compared with deferred antiretroviral therapy on CD4+ cell count recovery in early HIV infection.
    AIDS 2019;33:1335-1344.

  3. Amiry-Moghaddam M.
    AQP4 and the Fate of Gliomas.
    Cancer Res 2019;79:2810-2811.

  4. Casulo C.
    How I manage patients with follicular lymphoma.
    Br J Haematol 2019.

  5. Montano MA, Dombrowski JC, Dasgupta S, Golden MR, et al.
    Differences in STI Risk comparing PrEP users and propensity score-matched historical controls in a clinic setting.
    AIDS 2019.


Free Medical Abstracts
Privacy Policy

© Amedeo 1997-2016